Event Summary:

Personalized medicine encompasses much more than genetics. New technologies and achievements in science have brought us a whole new way of thinking in medicine. In this forum, you can learn from the most experienced companies how to explore this field of huge medical and commercial potential. Get the most useful information in valuable presentations, interactive panel discussions, and networking coffee breaks & cocktail reception.

Key Speakers:

Giuseppe Colucci, Roche Molecular Systems-RIC
Medical Manager Scientific Affairs

David Chen, Sanofi-Aventis
Clinical Research Director, Experimental
Medicine

Duncan McHale, Pfizer Global R & D
Senior Director and Head Molecular Profiling

Steffen Stürzebecher, Schering AG
Head of Global Pharmacogenomics, Global Preclinical Development

Key topics:

Which pharmaceutical areas can benefit most from personalized medicine?

Moving from Pharmacogenetic Effect to Personalized Medicine

What is the role of molecular diagnostic/predictive markers in this field?

Pharmacogenomics as a phase IV activity and a product life cycle management tool

Who should attend:

Vice Presidents, Heads, Senior Level Directors and Managers working in: R&D, Pharmaceutical Development, Pharmacogenomics, Exploratory Medicine, Clinical Development, Diagnostics, Business Development, Genomics, Clinical Research

Advanced Info (url):

http://www.jacobfleming.com/buxus/generate_page.php?page_id=238